|
99 Companies |
|
114 Products |
|
114 Products |
|
61 Mechanisms of Action |
|
11 Trials |
|
1875 News |
|
| «12...25262728293031323334353637» |
- AZD1386 / AstraZeneca
Enrollment change: Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee (clinicaltrials.gov) - May 27, 2012
P2, N=241, Terminated, Sponsor: AstraZeneca
N=520 --> 241
- ||| Trial completion, Adherence: CONVOY: Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) (clinicaltrials.gov) - May 27, 2012
P=N/A, N=102, Completed, Sponsor: AstraZeneca
N=520 --> 241 Recruiting --> Completed
- Clinical: A Pilot Study to Improve Patient-Doctor Communication (clinicaltrials.gov) - May 24, 2012
P=N/A, N=106, Completed, Sponsor: Walter Reed National Military Medical Center
- Trial completion: Reaching Exercise Goals: Comparison of Exercise Means in Patients With Knee Osteoarthritis (clinicaltrials.gov) - May 22, 2012
P=N/A, N=60, Completed, Sponsor: Penn State University
Recruiting --> Completed Recruiting --> Completed
- remifentanil / Generic mfg.
Clinical: Early Mobilization After Total Knee Arthroplasty (clinicaltrials.gov) - May 21, 2012
P=N/A, N=60, Completed, Sponsor: Region Skane
- Clinical: REHABITIC: Interactive Virtual Telerehabilitation After Total Knee Arthroplasty (clinicaltrials.gov) - May 21, 2012
P=N/A, N=140, Completed, Sponsor: Parc de Salut Mar
- ||||| Shinbaro (GCSB-5) / GC Biopharma, LG Chem
New P4 trial: To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis (clinicaltrials.gov) - May 21, 2012
P4, N=761, Completed, Sponsor: Green Cross Corporation
- Clinical: Nuclear Magnetic Resonance Therapy in Knee Osteoarthrosis (clinicaltrials.gov) - May 17, 2012
P=N/A, N=100, Completed, Sponsor: NHS Grampian
- Trial withdrawal: Post-Market Study of the EPIK Knee System (clinicaltrials.gov) - May 13, 2012
P=N/A, N=0, Withdrawn, Sponsor: Encore Medical, L.P.
Recruiting --> Completed Recruiting --> Withdrawn
- Enrollment change: Post-Market Study of the EPIK Knee System (clinicaltrials.gov) - May 13, 2012
P=N/A, N=0, Withdrawn, Sponsor: Encore Medical, L.P.
Recruiting --> Withdrawn N=100 --> 0
- ||||| SAR 113945 / Sanofi
New P2 trial: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II (clinicaltrials.gov) - May 13, 2012
P2, N=85, Completed, Sponsor: Sanofi
- Biomarker, Trial completion: A Study to Determine if Aquamin Modulates Inflammatory Biomarkers in the Blood of Osteoarthritis and Healthy Subjects (clinicaltrials.gov) - May 13, 2012
P2, N=36, Completed, Sponsor: Andrea Doolan
N=100 --> 0 Recruiting --> Completed
- Trial completion, Surgery, Bariatric surgery: The Effects of Bariatric Surgery Weight Loss on Knee Pain in Patients With Osteoarthritis of the Knee (clinicaltrials.gov) - May 7, 2012
P=N/A, N=30, Completed, Sponsor: Penn State University
Recruiting --> Completed Recruiting --> Completed
- || Trial initiation date: A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty (clinicaltrials.gov) - May 3, 2012
P=N/A, N=77, Active, not recruiting, Sponsor: Biomet, Inc.
Recruiting --> Completed Initiation date: Mar 2006 --> Jun 2012
- |||| etoricoxib / Generic mfg.
Trial completion: Efficacy of Etoricoxib 60 mg in Modifying Pain Hypersensitivity in People With Knee Osteoarthritis (clinicaltrials.gov) - Apr 30, 2012
P4, N=80, Completed, Sponsor: Curtin University of Technology
Initiation date: Mar 2006 --> Jun 2012 Recruiting --> Completed
- | Enrollment closed: KDD&MSV: Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells (clinicaltrials.gov) - Apr 27, 2012
P1/2, N=12, Active, not recruiting, Sponsor: Red de Terapia Celular
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||| ABT-652 / AbbVie
Trial completion, Combination therapy: A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee (clinicaltrials.gov) - Apr 26, 2012
P2, N=202, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| FX005 / Pacira
Trial completion: Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the Knee (clinicaltrials.gov) - Apr 26, 2012
P1/2, N=140, Completed, Sponsor: Flexion Therapeutics, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| New P4 trial: A Study of the Efficacy and Safety of Synvisc (clinicaltrials.gov) - Apr 24, 2012
P4, N=237, Completed, Sponsor: Sanofi
- | Durolane (sodium hyaluronate) / Bioventus
New P1/2 trial, Stroma: MSV_allo: Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (clinicaltrials.gov) - Apr 24, 2012
P1/2, N=30, Recruiting, Sponsor: Red de Terapia Celular
- || Enrollment closed: R3 (clinicaltrials.gov) - Apr 24, 2012
P=N/A, N=158, Active, not recruiting, Sponsor: Smith & Nephew, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial initiation date: Comparison of Anesthetic Techniques on Total Hip Arthroplasty (clinicaltrials.gov) - Apr 21, 2012
P=N/A, N=70, Not yet recruiting, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Active, not recruiting Initiation date: Jul 2011 --> Jul 2012
- | Enrollment closed: VIDEO: VItamin D Effect on Osteoarthritis Study (clinicaltrials.gov) - Apr 18, 2012
P3, N=400, Active, not recruiting, Sponsor: Menzies Research Institute Tasmania
Initiation date: Jul 2011 --> Jul 2012 Recruiting --> Active, not recruiting
- ||||||| Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Trial completion: Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury (clinicaltrials.gov) - Apr 18, 2012
P3, N=104, Completed, Sponsor: Medipost Co Ltd.
Recruiting --> Active, not recruiting Recruiting --> Completed
- Clinical: Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=200, Completed, Sponsor: Joint Implant Surgeons, Inc.
- | Enrollment open: Enhancing the Effectiveness of Physical Therapy for People With Knee Osteoarthritis (clinicaltrials.gov) - Apr 17, 2012
P2/3, N=300, Recruiting, Sponsor: Agency for Healthcare Research and Quality (AHRQ)
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| Enrollment change: Tapentadol (CG5503) (clinicaltrials.gov) - Apr 15, 2012
P3, N=1030, Completed, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Not yet recruiting --> Recruiting N=383 --> 1030
- Pennsaid (diclofenac sodium topical solution 1.5%) / Miravo
Clinical: Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis (clinicaltrials.gov) - Apr 15, 2012
P=N/A, N=0, Approved for marketing, Sponsor: Mallinckrodt
- Trial completion, Surgery: Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery (clinicaltrials.gov) - Apr 12, 2012
P4, N=30, Completed, Sponsor: Ottawa Hospital Research Institute
N=383 --> 1030 Recruiting --> Completed
- New P2 trial, Surgery: Functional Outcome in Two Types of Total Knee Replacement Surgery for People With Osteoarthritis (clinicaltrials.gov) - Apr 9, 2012
P2, N=30, Completed, Sponsor: Queen Margaret University
- |||||||||| New P3 trial: Active Drug Comparative, Multi-center, phase3 Clinical Study to Evaluate the Efficacy and Safety of PG201 in Osteoarthritis Patients (clinicaltrials.gov) - Apr 3, 2012
P3, N=309, Completed, Sponsor: PMG Pharm Co., Ltd
- Enrollment closed: Resistance Exercise and Knee Osteoarthritis Pain, Functional Impairment and Cartilage Turnover (clinicaltrials.gov) - Mar 28, 2012
P=N/A, N=90, Active, not recruiting, Sponsor: University of Florida
Recruiting --> Completed Recruiting --> Active, not recruiting
- New P3 trial: Osteoarthritis in Older Adults: Recovery of Mobility and Pain With a Topical Analgesic (clinicaltrials.gov) - Mar 25, 2012
P3, N=50, Not yet recruiting, Sponsor: University of Chile
- | Trial suspension: Gender Solutions Natural Knee Post-Market Study (clinicaltrials.gov) - Mar 20, 2012
P=N/A, N=300, Suspended, Sponsor: Zimmer, Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Suspended
- Enrollment change: Trilogy AB Acetabular Hip System Post Approval Study (clinicaltrials.gov) - Mar 20, 2012
P4, N=32, Terminated, Sponsor: Zimmer, Inc.
Not yet recruiting --> Suspended N=250 --> 32
- |||||||||| Remoxy ER (extended-release oxycodone capsules CII) / Cassava
New P3 trial: Long-term Safety of PF-00345439 (Oxycodone) (clinicaltrials.gov) - Mar 19, 2012
P3, N=823, Completed, Sponsor: Pfizer
- ||| Enrollment closed: Joins_Carp_?: Assessment of Protective Effect of JOINS on Cartilage in Knee Osteoarthritis (clinicaltrials.gov) - Mar 19, 2012
P4, N=76, Active, not recruiting, Sponsor: SK Chemicals Co.,Ltd.
N=250 --> 32 Recruiting --> Active, not recruiting
- | Euflexxa (hyaluronic acid) / Ferring
New P4 trial: Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis (clinicaltrials.gov) - Mar 18, 2012
P4, N=207, Completed, Sponsor: American Orthopaedic Society for Sports Medicine
- ||| Clinical: Epidemiology of Osteoarthritis (OA) Pain (clinicaltrials.gov) - Mar 15, 2012
P=N/A, N=60, Recruiting, Sponsor: Northwestern University
- ||||| duloxetine / Generic mfg.
New P4 trial: Duloxetine in Osteoarthritis (OA) Pain (clinicaltrials.gov) - Mar 15, 2012
P4, N=120, Active, not recruiting, Sponsor: Northwestern University
- Clinical: Role of Autologous Platelet Rich Plasma in Total Knee Arthroplasty (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=40, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
- ||| Clinical: AposTherapy for Singaporean Patients With Knee Osteoarthritis (OA) (clinicaltrials.gov) - Mar 13, 2012
P=N/A, N=60, Completed, Sponsor: Apos Medical and Sports Technology Ltd.
- duloxetine / Generic mfg.
Trial initiation date: OASIS: Osteoarthritis Sensitivity Integration Study (clinicaltrials.gov) - Mar 12, 2012
P4, N=70, Recruiting, Sponsor: University of Michigan
Recruiting --> Active, not recruiting Initiation date: Jun 2011 --> Sep 2011
- duloxetine / Generic mfg.
Enrollment open: OASIS: Osteoarthritis Sensitivity Integration Study (clinicaltrials.gov) - Mar 12, 2012
P4, N=70, Recruiting, Sponsor: University of Michigan
Initiation date: Jun 2011 --> Sep 2011 Active, not recruiting --> Recruiting
- Trial completion: Educational Intervention for Knee Pain (clinicaltrials.gov) - Mar 6, 2012
P=N/A, N=600, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- | Durolane (sodium hyaluronate) / Bioventus
New P4 trial: Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee (clinicaltrials.gov) - Mar 1, 2012
P4, N=290, Suspended, Sponsor: Bioventus LLC
- |||| Trial completion: Flexsure: A Study for Moderate Osteoarthritis of the Knee (clinicaltrials.gov) - Mar 1, 2012
P1/2, N=76, Completed, Sponsor: Vedic Lifesciences Pvt. Ltd.
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Pro Osteon Bone Void Filler Study (clinicaltrials.gov) - Feb 28, 2012
P=N/A, N=0, Withdrawn, Sponsor: Biomet, Inc.
Recruiting --> Completed N=20 --> 0
- Enrollment change: A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty (clinicaltrials.gov) - Feb 28, 2012
P=N/A, N=0, Withdrawn, Sponsor: Biomet Orthopedics, LLC
N=20 --> 0 N=150 --> 0
- ||| Trial completion: Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients (clinicaltrials.gov) - Feb 27, 2012
P=N/A, N=105, Completed, Sponsor: Biomet, Inc.
N=150 --> 0 Recruiting --> Completed